Eva Blozik
About
Eva Blozik is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology.
According to data from OpenAlex, Eva Blozik has authored 113 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Economics and Econometrics, 35 papers in General Health Professions and 30 papers in Epidemiology. Recurrent topics in Eva Blozik's work include Health Systems, Economic Evaluations, Quality of Life (33 papers), Chronic Disease Management Strategies (21 papers) and Heart Failure Treatment and Management (13 papers). Eva Blozik is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (33 papers), Chronic Disease Management Strategies (21 papers) and Heart Failure Treatment and Management (13 papers). Eva Blozik collaborates with scholars based in Switzerland, Germany and United States. Eva Blozik's co-authors include Andreas E. Stuck, Gerhard Gillmann, John C. Beck, Steve Iliffe, Martin Scherer, Thomas Kötter, Oliver Reich, Roland Rapold, Thomas Rosemann and Jan von Overbeck and has published in prestigious journals such as PLoS ONE, Diabetes Care and Scientific Reports.
In The Last Decade
Eva Blozik
111 papers receiving 3.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Eva Blozik Switzerland | 21 | 848 | 797 | 480 | 415 | 415 | 113 | 3.1k | ||
| Irena Cenzer United States | 28 | 1.1k 1.3× | 1.0k 1.3× | 496 1.0× | 486 1.2× | 241 0.6× | 79 | 3.4k | ||
| Catherine A. Sarkisian United States | 33 | 1.2k 1.5× | 702 0.9× | 502 1.0× | 278 0.7× | 462 1.1× | 119 | 4.1k | ||
| Ulf Jakobsson Sweden | 34 | 1.2k 1.4× | 412 0.5× | 461 1.0× | 261 0.6× | 329 0.8× | 118 | 3.5k | ||
| Gerhard Gillmann Switzerland | 17 | 1.0k 1.2× | 1.2k 1.5× | 376 0.8× | 449 1.1× | 205 0.5× | 31 | 2.8k | ||
| Matthew E. Dupre United States | 30 | 934 1.1× | 1.2k 1.5× | 249 0.5× | 305 0.7× | 226 0.5× | 84 | 3.2k | ||
| Nathan M. Stall Canada | 26 | 1.0k 1.2× | 342 0.4× | 377 0.8× | 372 0.9× | 228 0.5× | 113 | 2.7k | ||
| Terry Fulmer United States | 32 | 1.7k 2.0× | 787 1.0× | 766 1.6× | 683 1.6× | 372 0.9× | 118 | 3.5k | ||
| Ana Quiñones United States | 31 | 876 1.0× | 781 1.0× | 314 0.7× | 258 0.6× | 555 1.3× | 119 | 3.3k | ||
| Nancy Hoeymans Netherlands | 27 | 1.2k 1.4× | 913 1.1× | 366 0.8× | 269 0.6× | 772 1.9× | 66 | 3.7k | ||
| Carmen García‐Peña Mexico | 27 | 627 0.7× | 420 0.5× | 581 1.2× | 185 0.4× | 352 0.8× | 138 | 2.5k |
Countries citing papers authored by Eva Blozik
Since
Specialization
Citations
This map shows the geographic impact of Eva Blozik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Blozik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Blozik more than expected).
Fields of papers citing papers by Eva Blozik
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eva Blozik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Blozik. The network helps show where Eva Blozik may publish in the future.
Co-authorship network of co-authors of Eva Blozik
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Blozik. A scholar is included among the top collaborators of Eva Blozik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Blozik. Eva Blozik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Schäfer, Ingmar, Katharina Glassen, Heike Hansen, et al.. (2023). Validation of patient- and GP-reported core sets of quality indicators for older adults with multimorbidity in primary care: results of the cross-sectional observational MULTIqual validation study. BMC Medicine. 21(1). 148–148.
2.
Stephan, Brigitte, et al.. (2023). The Value of Hybrid Teledermatology in German Prisons: Analysis of Routine Telemedical Data. Telemedicine Journal and e-Health. 29(11). 1642–1649.
3.
Graber, Sereina M., et al.. (2023). Does the implementation of an incentive scheme increase adherence to diabetes guidelines? A retrospective cohort study of managed care enrollees. BMC Health Services Research. 23(1). 707–707.
4.
Blozik, Eva, et al.. (2023). Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Medical Weekly. 153(9). s3441–s3441.
5.
Reinau, Daphne, Nadine Schur, Eva Blozik, et al.. (2021). Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013–2019. Swiss Medical Weekly. 151(3536). w30018–w30018.
6.
Neuner‐Jehle, Stefan, Sereina M. Graber, Ellen Keizer, et al.. (2021). Time trends in general practitioners’ home visits for older patients: a retrospective cross-sectional study from Switzerland. Swiss Medical Weekly. 151(2728). w20539–w20539.
7.
Brüngger, Beat, Caroline Bähler, Matthias Schwenkglenks, et al.. (2021). Surgical procedures in inpatient versus outpatient settings and its potential impact on follow-up costs. Health Policy. 125(10). 1351–1358.
8.
Huber, Carola A., Martin Scherer, Roland Rapold, & Eva Blozik. (2020). Evidence-based quality indicators for primary healthcare in association with the risk of hospitalisation: a population-based cohort study in Switzerland. BMJ Open. 10(4). e032700–e032700.
9.
Gaisl, Thomas, Marc Meier, Silvana K. Rampini, et al.. (2020). The Swiss Prison Study (SWIPS): Protocol for Establishing a Public Health Registry of Prisoners in Switzerland. JMIR Research Protocols. 9(12). e23973–e23973.
10.
Huber, Carola A., et al.. (2020). <p>Trends in Micronutrient Laboratory Testing in Switzerland: A 7-Year Retrospective Analysis of Healthcare Claims Data</p>. International Journal of General Medicine. Volume 13. 1341–1348.
11.
Ulytė, Agnė, Caroline Bähler, Matthias Schwenkglenks, et al.. (2019). Measuring diabetes guideline adherence with claims data: systematic construction of indicators and related challenges. BMJ Open. 9(4). e027138–e027138.
12.
Huber, Carola A., et al.. (2019). <p>Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists</p>. Journal of Pain Research. Volume 12. 2211–2221.
13.
Huber, Carola A., Matthias R. Meyer, Jan Steffel, et al.. (2018). Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population. Clinical Therapeutics. 41(1). 107–117.
14.
Schmid, Martin, Oliver Reich, Eva Blozik, et al.. (2018). Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context. BMC Ophthalmology. 18(1). 64–64.
15.
Reich, Oliver, Martin Schmid, Roland Rapold, Lucas M. Bachmann, & Eva Blozik. (2017). Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland. BMC Ophthalmology. 17(1). 234–234.
16.
Blozik, Eva, Roland Rapold, Klaus Eichler, & Oliver Reich. (2017). Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015. Neuropsychiatric Disease and Treatment. Volume 13. 2737–2745.
17.
Eisele, Marion, Sigrid Boczor, Nadine Janis Pohontsch, et al.. (2017). Factors associated with general practitioners’ awareness of depression in primary care patients with heart failure: baseline-results from the observational RECODE-HF study. BMC Family Practice. 18(1). 71–71.
18.
Messerli, Markus, Eva Blozik, Noortje Vriends, & Kurt E. Hersberger. (2016). Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial. BMC Health Services Research. 16(1). 145–145.
19.
Blozik, Eva, Roland Rapold, Jan von Overbeck, & Oliver Reich. (2013). Polypharmacy and Potentially Inappropriate Medication in the Adult, Community-Dwelling Population in Switzerland. Drugs & Aging. 30(7). 561–568.
20.
Clough‐Gorr, Kerri M., Eva Blozik, Gerhard Gillmann, et al.. (2008). The Self-Administered 24-Item Geriatric Pain Measure (GPM-24-SA): Psychometric Properties in Three European Populations of Community-Dwelling Older Adults. Pain Medicine. 9(6). 695–709.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Irena Cenzer Breakdown of academic impact, for papers by Catherine A. Sarkisian Breakdown of academic impact, for papers by Ulf Jakobsson Breakdown of academic impact, for papers by Gerhard Gillmann Breakdown of academic impact, for papers by Matthew E. Dupre Breakdown of academic impact, for papers by Nathan M. Stall Breakdown of academic impact, for papers by Terry Fulmer Breakdown of academic impact, for papers by Ana Quiñones Breakdown of academic impact, for papers by Nancy Hoeymans Breakdown of academic impact, for papers by Carmen García‐Peña